Literature DB >> 3556218

Expression of ricin A chain in Escherichia coli.

M O'Hare, L M Roberts, P E Thorpe, G J Watson, B Prior, J M Lord.   

Abstract

DNA encoding ricin A chain was derived from preproricin cDNA and ligated into the expression vector pDS5/3. Transcription is controlled from the coliphage promoter PN25 fused with the lac operator of E.coli. When induced, E.coli 71.18 cells transformed with the recombinant plasmid express ricin A chain which is soluble and has full biological activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556218     DOI: 10.1016/0014-5793(87)80759-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.

Authors:  D Castelletti; G Fracasso; S Righetti; G Tridente; R Schnell; A Engert; M Colombatti
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  The influence of anti-(ricin toxin A chain) monoclonal antibodies on the pharmacokinetics of ricin toxin A chain and recombinant ricin A chain in mice.

Authors:  M V Pimm; B Gunn; J M Lord; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes.

Authors:  D Schlossman; D Withers; P Welsh; A Alexander; J Robertus; A Frankel
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

4.  Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice.

Authors:  M V Pimm; R A Robins; R W Baldwin
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.

Authors:  A Frankel; D Schlossman; P Welsh; A Hertler; D Withers; S Johnston
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 6.  Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.

Authors:  E S Vitetta
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

7.  Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.

Authors:  M Tommasi; D Castelletti; M Pasti; G Fracasso; I Lorenzetti; S Sartoris; C Pera; G B Ferrara; G Tridente; M Colombatti
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

8.  Ribosome depurination is not sufficient for ricin-mediated cell death in Saccharomyces cerevisiae.

Authors:  Xiao-Ping Li; Marianne Baricevic; Hemalatha Saidasan; Nilgun E Tumer
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

9.  Effects of ribosome-inactivating proteins on Escherichia coli and Agrobacterium tumefaciens translation systems.

Authors:  T Girbés; L Barbieri; M Ferreras; F J Arias; M A Rojo; R Iglesias; C Alegre; C Escarmis; F Stirpe
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

10.  Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.

Authors:  V S Byers; E B Austin; J A Clegg; G Denton; B Gunn; D Hooi; F Hudecz; M R Price; R W Baldwin
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.